These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38503527)

  • 21. Novel antibodies to the donor stem cell population CD34+/VEGFR-2+ are associated with rejection after hematopoietic stem cell transplantation.
    Nordlander A; Mattsson J; Sundberg B; Sumitran-Holgersson S
    Transplantation; 2008 Sep; 86(5):686-96. PubMed ID: 18791450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution.
    Dao MA; Arevalo J; Nolta JA
    Blood; 2003 Jan; 101(1):112-8. PubMed ID: 12393633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD34
    Mohty R; Brissot E; Battipaglia G; Ruggeri A; Sestili S; Mediavilla C; Belhocine R; Dulery R; Mohty M; Malard F
    Curr Res Transl Med; 2019 Aug; 67(3):112-114. PubMed ID: 30591374
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.
    Lang P; Schumm M; Greil J; Bader P; Klingebiel T; Müller I; Feuchtinger T; Pfeiffer M; Schlegel PG; Niethammer D; Handgretinger R
    Klin Padiatr; 2005; 217(6):334-8. PubMed ID: 16307419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.
    Altès A; Sierra J; Esteve J; Martín-Henao G; Marín P; Sureda A; Briones J; Martino R; Villamor N; Colomer D; Carreras E; Garcia J; Brunet S; Montserrat E
    Exp Hematol; 2002 Jul; 30(7):824-30. PubMed ID: 12135682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late cytomegalovirus polyradiculopathy following haploidentical CD34+-selected hematopoietic stem cell transplantation.
    Zeiser R; Grüllich C; Bertz H; Pantazis G; Hufert FT; Bley TA; Finke J
    Bone Marrow Transplant; 2004 Jan; 33(2):243-5. PubMed ID: 14716290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of G₀ state by CD34-positive cord blood cells after bone marrow transplantation.
    Shima H; Takubo K; Tago N; Iwasaki H; Arai F; Takahashi T; Suda T
    Exp Hematol; 2010 Dec; 38(12):1231-40. PubMed ID: 20800645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.
    Lemoli RM; Fortuna A; Motta MR; Rizzi S; Giudice V; Nannetti A; Martinelli G; Cavo M; Amabile M; Mangianti S; Fogli M; Conte R; Tura S
    Blood; 1996 Feb; 87(4):1625-34. PubMed ID: 8608257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.
    Vose JM; Bierman PJ; Lynch JC; Atkinson K; Juttner C; Hanania CE; Bociek G; Armitage JO
    Biol Blood Marrow Transplant; 2001; 7(12):680-7. PubMed ID: 11787531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The Characteristics of T Lymphocyte Reconstitution after Haploid Hematopoietic Stem Cell Transplantation in SAA and Its Relationship with aGVHD].
    Tian Q; Zhu QJ; Wang T; Gong R; Tian WW; Gao ZL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):532-538. PubMed ID: 37096530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of CD34(+) cell transplantation in children with neuroblastoma.
    Kanold J; Yakouben K; Tchirkov A; Carret AS; Vannier JP; LeGall E; Bordigoni P; Deméocq F
    Med Pediatr Oncol; 2000 Jul; 35(1):1-7. PubMed ID: 10881000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    Osawa M; Hanada K; Hamada H; Nakauchi H
    Science; 1996 Jul; 273(5272):242-5. PubMed ID: 8662508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.
    Laport GG; Levine BL; Stadtmauer EA; Schuster SJ; Luger SM; Grupp S; Bunin N; Strobl FJ; Cotte J; Zheng Z; Gregson B; Rivers P; Vonderheide RH; Liebowitz DN; Porter DL; June CH
    Blood; 2003 Sep; 102(6):2004-13. PubMed ID: 12763934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7.
    Gallacher L; Murdoch B; Wu DM; Karanu FN; Keeney M; Bhatia M
    Blood; 2000 May; 95(9):2813-20. PubMed ID: 10779426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Absolute numbers of peripheral blood CD34+ hematopoietic stem cells prior to a leukapheresis procedure as a parameter predicting the efficiency of stem cell collection].
    Galtseva IV; Davydova YO; Gaponova TV; Kapranov NM; Kuzmina LA; Troitskaya VV; Gribanova EO; Kravchenko SK; Mangasarova YK; Zvonkov EE; Parovichnikova EN; Mendeleeva LP; Savchenko VG
    Ter Arkh; 2017; 89(7):18-24. PubMed ID: 28766536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: effect of the CD34+ cell dose.
    Diaz MA; Vicent MG; Garcia-Sanchez F; Vicario JL; Madero L
    Vox Sang; 2000; 79(3):145-50. PubMed ID: 11111232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo.
    DiGiusto DL; Lee R; Moon J; Moss K; O'Toole T; Voytovich A; Webster D; Mule JJ
    Blood; 1996 Feb; 87(4):1261-71. PubMed ID: 8608214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [CDw90 (Thy-1) expression on CD34 positive cells in peripheral blood stem cell harvest].
    Miyamoto K; Otsuka T; Mizuno S; Funatsu K; Inaba R
    Rinsho Ketsueki; 1997 Jan; 38(1):9-13. PubMed ID: 9028155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enumeration of CD34+ hematopoietic precursor cells: current status.
    Reis MD
    Transplant Proc; 1999 Nov; 31(7):2970-2. PubMed ID: 10578353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.